Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Neoplasms × alectinib × Clear all

Phase

Phase 2 2 Phase 1/2 2 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Propofol 6 Carboplatin 5 Sevoflurane 4 Saline Solution 3 Paclitaxel 3 Nivolumab 3 Erlotinib Hydrochloride 3 Acetaminophen 3 Pemetrexed 2 Midazolam 2 Lidocaine 2 Isoflurane 2 Docetaxel 2 Desflurane 2 Cryotherapy 2 Bupivacaine 2 Bronchoscopy 2 Anesthesia, Inhalation 2 trametinib 1 sotorasib 1 pegfilgrastim 1 icotinib 1 endostar protein 1 durvalumab 1 dabrafenib 1 capmatinib 1 camrelizumab 1 beta Carotene 1 atezolizumab 1 alectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525338 2024-05-13

ADAPT ALEC

University Medical Center Groningen

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡